Chemo fog is one of the most serious health concerns encountered by cancer survivors
receiving doxorubicin (DOX)-based chemotherapy. Oxidative stress, neuroinflammation …

Increasing studies demonstrated that air pollution (PM2. 5) plays a significant role in
metabolic and neurological diseases. Unfortunately, there is no direct testimony of this, and …

Objective This study aimed to investigate the effect of resveratrol (Res) on paclitaxel (PTX)-
induced cognitive impairment and elucidate the underlying molecular mechanisms. Methods …

Background/aim Doxorubicin (DOX) is a highly effective chemotherapy medicine commonly
used to treat breast cancer; yet, despite its clinical efficacy, it usually causes chemobrain. As …

Although doxorubicin (Dox) is an effective chemotherapy medication used extensively in the
treatment of breast cancer, it frequently causes debilitating neurological deficits known as …

Chemotherapy-induced cognitive impairment (CICI) is widely recognized as a frequent
adverse side effect following the administration of chemotherapeutic agents. This study …

Cancer chemotherapy is known to cause cognitive defects in patients. Our study
investigated the effect of piracetam (PIRA; 200 or 400 mg/kg) against doxorubicin (DOX) …

Purpose Depression is a mood disorder accompanied by intensive molecular and
neurochemical alterations. Currently, available antidepressant therapies are not fully …

Summary Aims Vascular dementia (VaD) is a heterogeneous brain disorder for which there
are no effective approved pharmacological treatments available. We aimed to evaluate the …

Cancer chemotherapy-induced cognitive impairment (chemobrain) is a major complication
that affects the prognosis of therapy. Our study evaluates the nootropic-like activity of …